Skip to main content
SpringerLink
Log in
Book cover

Principles of Adult Surgical Critical Care pp 369–380Cite as

Hyperadrenergic Crisis

  • Chapter
  • First Online:

  • 2207 Accesses

Abstract

The patient is a 40-year-old nurse who presented with a hypertensive crisis due to an unrecognized pheochromocytoma. The patient had no significant past medical history or family history and developed hypertension 2 years prior to her event at age 38. In the 6 months prior to her event, her blood pressure was more difficult to control. She also developed diabetes with highly variable glucose levels also difficult to control. She had had a 1-year history of headaches, diaphoresis, and palpitations. She presented to the emergency room after a witnessed collapse at home. Her initial blood pressure was 210/125, heart rate 135, and very short of breath. She was intubated and was difficult to ventilate. Her echocardiogram showed a moderately dilated left ventricle with an LVEF of 15 % and moderate to severe mitral regurgitation. She underwent cardiac catheterization that showed normal coronary arteries. She was transferred by helicopter to our institution to be placed on ECMO. At our institution she was treated with intravenous nicardipine, phenoxybenzamine, and metyrosine. A repeat cardiac echo showed an LVEF of 30 % and her blood pressure was 180/110. Imaging demonstrated 7 cm left adrenal mass. Laboratory testing showed a plasma epinephrine of >30,000 pg/ml (ULN 200) and plasma norepinephrine of 35,556 pg/ml (ULN 520). She remained intubated in the ICU during blood pressure control. On hospital day 6, she underwent an uneventful laparoscopic left adrenalectomy. Final pathology showed a relatively benign pheochromocytoma (PASS score of 4). She was extubated on postoperative day #1 and was discharged to home on postoperative day #3.

This is a preview of subscription content, log in via an institution.

References

  1. Elder EE, Elder G, Larsson C. Pheochromocytoma and functional paraganglioma syndrome: no longer the 10% tumor. J Surg Oncol. 2005;89:193–201.

    PubMed  Google Scholar 

  2. Brouwers FM, et al. Emergencies caused by pheochromocytoma, neuroblastoma, or ganglioneuroma. Endocrinol Metab Clin N Am. 2006;35:699–724.

    CAS  Google Scholar 

  3. Chen H, Sippel RS, Pacak K. The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma & medullary thyroid cancer. Pancreas. 2010;39(6):775–83.

    PubMed  PubMed Central  Google Scholar 

  4. Whitelaw BC, et al. Pheochromocytoma crisis. Clin Endocrinol. 2014;80:13–22.

    CAS  Google Scholar 

  5. Newell KA, et al. Pheochromocytoma multisystem crisis. A surgical emergency. Arch Surg. 1988;123:956–9.

    CAS  PubMed  Google Scholar 

  6. Amar L, Eisenhofer G. Diagnosing phaeochromocytoma/paraganglioma in a patient presenting with critical illness: biochemistry versus imaging. Clin Endocrinol. 2015;83:298–302.

    Google Scholar 

  7. Tucci V, Sokari T. The clinical manifestations, diagnosis and treatment of adrenal emergencies. Emerg Med Clin North Am. 2014;32:465–84.

    PubMed  Google Scholar 

  8. Lenders JWM, et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99:1915–42.

    CAS  PubMed  Google Scholar 

  9. Bergland BE. Pheochromocytoma presenting as shock. Am J Emerg Med. 1989;7(1):44–8.

    CAS  PubMed  Google Scholar 

  10. Lee T-W, et al. Pheochromoctyoma mimicking both acute coronary syndrome and sepsis: a case report. Med Princ Pract. 2012;22:405–7.

    PubMed  PubMed Central  Google Scholar 

  11. Salinas CL, et al. Emergency adrenalectomy due to acute heart failure secondary to complicated pheochromocytoma: a case report. World J Surg Oncol. 2011;9:49.

    PubMed  PubMed Central  Google Scholar 

  12. Steppan J, Shields J, Lebron R. Pheochromocytoma presenting as acute heart failure leading to cardiogenic shock and multiorgan failure. Case Rep Med. 2011;2011:596354.

    PubMed  PubMed Central  Google Scholar 

  13. Chao A, et al. Phaeochromocytoma crisis – a rare indication for extracorporeal membrane oxygenation. Anaesthesia. 2008;63:86–8.

    CAS  PubMed  Google Scholar 

  14. Lin PC, et al. Pheochromocytoma underlying hypertension, stroke and dilated cardiomyopathy. Tex Heart Inst J. 2007;34:244–6.

    PubMed  PubMed Central  Google Scholar 

  15. Kelley SR, Goel TK, Smith JM. Pheochromocytoma presenting as acute severe congestive heart failure, dilated cardiomyopathy, and severe mitral valvular regurgitation: a case report and review of the literature. J Surg Educ. 2009;66(2):96–101.

    PubMed  Google Scholar 

  16. Wu X-M, et al. Pheochromocytoma presenting as acute myocarditis with cardiogenic shock in two cases. Intern Med. 2008;47:2125–55.

    Google Scholar 

  17. Brukamp K, et al. Rapidly reversible cardiogenic shock as a pheochromocytoma presentation. Am J Med. 2007;120:e1–2.

    PubMed  Google Scholar 

  18. Okada Y, et al. Noncardiogenic pulmonary edema as the chief manifestation of a pheochromocytoma: a case report of MEN 2A with pedigree analysis of the RET proto-oncogene. Tohoku J Exp Med. 1999;188:177–87.

    CAS  PubMed  Google Scholar 

  19. Sukoh N, et al. Increased neutrophils in bronchoalveolar lavage fluids from a patient with pulmonary edema associated with pheochromocytoma. Intern Med. 2004;43(12):1194–7.

    PubMed  Google Scholar 

  20. Fahmy N, et al. Postoperative acute pulmonary edema: a rare presentation of pheochromocytoma. Clin Nephrol. 1997;48(2):122–4.

    CAS  PubMed  Google Scholar 

  21. Kamari Y, et al. Peripartum hypertension from pheochromocytoma: a rare and challenging entity. Am J Hypertens. 2005;18(10):1306–12.

    PubMed  Google Scholar 

  22. Kaye J, et al. Pheochromocytoma presenting as life-threatening pulmonary edema. Endocrine. 2001;15(2):203–4.

    CAS  PubMed  Google Scholar 

  23. Kizer JR, et al. Pheochromocytoma crisis, cardiomyopathy, and hemodynamic collapse. Chest. 2000;118:1221–3.

    CAS  PubMed  Google Scholar 

  24. Mitchell L, Bellis F. Pheochromocytoma – “The Great Mimic”: an unusual presentation. Emerg Med J. 2007;24:672–3.

    PubMed  PubMed Central  Google Scholar 

  25. Yoshida T, Ishihara H. Pheochromocytoma presenting as massive hemoptysis and acute respiratory failure. Am J Emerg Med. 2009;27(5):626.e3–4.

    PubMed  Google Scholar 

  26. Tack CJ, Lenders JW. Pheochromocytoma as a cause of blue toes. Arch Intern Med. 1993;153(17):2061.

    CAS  PubMed  Google Scholar 

  27. Radtke WE, et al. Cardiovascular complications of pheochromocytoma crisis. Am J Cardiol. 1975;35:701–5.

    CAS  PubMed  Google Scholar 

  28. O’Neal PB, et al. Hemorrhagic shock as the initial manifestation of pheochromocytoma: report of sequential management strategy. Endocr Pract. 2012;18(4):e81–4.

    PubMed  Google Scholar 

  29. Hendrickson RJ, et al. Management of massive retroperitoneal hemorrhage from an adrenal tumor. Endocr J. 2001;48(6):691–6.

    CAS  PubMed  Google Scholar 

  30. de Wilde D, et al. The paradox of hypotension and pheochromocytoma: a case report. Eur J Emerg Med. 2004;11:237–9.

    PubMed  Google Scholar 

  31. Winter C, et al. Fatal form of phaeochromocytoma presenting as acute pyelonephritis. Eur J Anaesthesiol. 2001;18(8):548–53.

    CAS  PubMed  Google Scholar 

  32. Shemin D, Cohn PS, Zipin SB. Pheochromocytoma presenting as rhabdomyolysis and acute myoglobinuric renal failure. Arch Intern Med. 1990;150(11):2384–5.

    CAS  PubMed  Google Scholar 

  33. Hill JB, Schwartzman RJ. Cerebral infarction and disseminated intravascular coagulation with pheochromocytoma. Arch Neurol. 1981;38(6):395.

    CAS  PubMed  Google Scholar 

  34. Moritani H, et al. Pheochromocytoma of the urinary bladder revealed with cerebral hemorrhage. Intern Med. 2001;40(7):638–42.

    CAS  PubMed  Google Scholar 

  35. Leiba A, et al. Seizures as a presenting symptom of phaeochromocytoma in a young soldier. J Hum Hypertens. 2003;17(1):73–5.

    CAS  PubMed  Google Scholar 

  36. Herbland A, et al. Multiple organ failure as initial presentation of pheochromocytoma. Am J Emerg Med. 2005;23:565–6.

    PubMed  Google Scholar 

  37. Kohle N, et al. Hypertension due to pheochromocytoma – an unusual cause of multiorgan failure. Nephrol Dial Transplant. 2001;16:2100–4.

    Google Scholar 

  38. Moran ME, Rosenberg DJ, Zornow DH. Pheochromocytoma multisystem crisis. Urology. 2006;67:846.e19–20.

    PubMed  Google Scholar 

  39. Sethi PS, et al. Fatal pheochromocytoma crisis precipitated by dobutamine stress echocardiography. Eur J Echocardiogr. 2008;9:819–21.

    PubMed  Google Scholar 

  40. Lenders JWM. Pheochromocytoma and pregnancy: a deceptive connection. Eur J Endocrinol. 2012;166:143–50.

    CAS  PubMed  Google Scholar 

  41. Brunt LM. Phaeochromocytoma in pregnancy. Br J Surg. 2001;88:481–3.

    CAS  PubMed  Google Scholar 

  42. Oishi S, Sato T. Pheochromocytoma in pregnancy: a review of the Japanese literature. Endocr J. 1994;41(3):219–25.

    CAS  PubMed  Google Scholar 

  43. Harper MA, et al. Phaeochromocytoma in pregnancy. Five cases and a review of the literature. Br J Obstet Gynaecol. 1989;96(5):594–606.

    CAS  PubMed  Google Scholar 

  44. Ueda T, et al. Pheochromoctyoma presenting as recurrent hypotension and syncope. Internal. 2005;44(3):222–7.

    Google Scholar 

  45. De Leeuw PW, Waltman FL, Birkenhager WH. Noncardiogenic pulmonary edema as the sole manifestation of pheochromocytoma. Hypertension. 1986;8(9):810–2.

    PubMed  Google Scholar 

  46. Schifferdecker B, et al. Adrenergic shock – an overlooked clinical entity. Cardiology. 2005;13(2):69–72.

    Google Scholar 

  47. Takizawa M, et al. A case of transient left ventricular ballooning with pheochromocytoma, supporting pathogenic role of catecholamines in stress-induced cardiomyopathy or Takotsubo cardiomyopathy. Int J Cardiol. 2007;114:e15–7.

    PubMed  Google Scholar 

  48. Sanchez-Recalde A, et al. Pheochromocytoma-related cardiomyopathy: inverted Takatsubo contractile pattern. Circulation. 2006;113(17):e738–9.

    PubMed  Google Scholar 

  49. Van Vliet PD, Burchell HB, Titus JL. Focal myocarditis associated with pheochromocytoma. N Engl J Med. 1966;274(20):1102–8.

    PubMed  Google Scholar 

  50. Mobine HR, et al. Pheochromocytoma-induced cardiomyopathy is modulated by the synergistic effects of cell-secreted factors. Circ Heart Fail. 2009;2:121–8.

    PubMed  PubMed Central  Google Scholar 

  51. Minetto M, et al. Interleukin-6 producing pheochromocytoma presenting with acute inflammatory syndrome. J Endocrinol Invest. 2003;26(5):453–7.

    CAS  PubMed  Google Scholar 

  52. Kang JM, et al. Systemic inflammatory syndrome and hepatic inflammatory cell infiltration caused by pheochromocytoma. Endocr J. 2005;52(2):193–8.

    PubMed  Google Scholar 

  53. Saxena N, Parry-Jones AJD. Traumatic haemorrhage into an occult phaeochromocytoma: presentation and management in a patient with septic shock. Anaesthesia. 2008;63:428–32.

    CAS  PubMed  Google Scholar 

  54. Vanderveen KA, et al. Biopsy of pheochromocytomas and paragangliomas: potential for disaster. Surgery. 2009;146:1158–66.

    PubMed  Google Scholar 

  55. Dabbous A, Siddik-Sayyid S, Baraka A. Catastrophic hemodynamic changes in a patient with undiagnosed pheochromocytoma undergoing abdominal hysterectomy. Anesth Analg. 2007;104(1):223–4.

    PubMed  Google Scholar 

  56. THomas DJB, et al. Adrenergic crisis due to pheochromocytoma. Br Med J. 1977;1:688–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  57. Bessell-Browne R, O’Malley ME. CT of pheochromocytoma and paraganglioma: risk of adverse events with IV administration of nonionic contrast material. AJR Am J Roentgenol. 2007;199:970–4.

    Google Scholar 

  58. Sibal L, et al. Pheochromocytomas presenting as acute crises after beta blockade therapy. Clin Endocrinol. 2006;65:186–90.

    CAS  Google Scholar 

  59. Sheinberg R, et al. A perfect storm: fatality resulting from metoclopramide unmasking a pheochromocytoma and its management. J Cardiothorac Vasc Anesth. 2012;26(1):161–5.

    PubMed  Google Scholar 

  60. Takai Y, Seki H, Kinoshita K. Pheochromocytoma in pregnancy manifesting hypertensive crisis induced by metoclopramide. Int J Gynecol Obstet. 1997;59:133–7.

    CAS  Google Scholar 

  61. van Lennep JR, Romijn JA, Harinck HIJ. Multi-organ failure after a glucagon test. Lancet. 2007;369:798.

    PubMed  Google Scholar 

  62. Eisenhofer G, et al. Adverse drug reactions in patients with phaeochromocytoma: incidence, prevention and management. Drug Saf. 2007;30(11):1031–62.

    CAS  PubMed  Google Scholar 

  63. Sizemore GW, et al. Hypertensive crisis, catecholamine cardiomyopathy and death associated with pheochromocytoma. Endocr Pract. 2008;14(1):93–6.

    PubMed  Google Scholar 

  64. Ferguson KL. Imipramine-provoked paradoxical pheochromocytoma crisis: a case of cardiogenic shock. Am J Emerg Med. 1994;12(2):190–2.

    CAS  PubMed  Google Scholar 

  65. Yi DW, et al. Pheochromocytoma crisis after a dexamethasone suppression test for adrenal incidentaloma. Endocrinology. 2010;37:213–9.

    CAS  Google Scholar 

  66. Rosas AL, et al. Pheochromocytoma crisis induced by glucocorticoids: a report of four cases and review of the literature. Eur J Endocrinol. 2008;158:423–9.

    CAS  PubMed  Google Scholar 

  67. Pacak K, et al. Pheochromocytoma: recommendations for practice from the first international symposium. Nat Clin Pract Endocrinol Metab. 2007;3(2):92–102.

    PubMed  Google Scholar 

  68. Eisenhofer G, et al. Understanding catecholamine metabolism as a guide to the biochemical diagnosis of pheochromocytoma. Rev Endocr Metab Disord. 2001;2(3):297–311.

    CAS  PubMed  Google Scholar 

  69. Eisenhofer G, et al. Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results. J Clin Endocrinol Metab. 2003;88(6):2656–66.

    CAS  PubMed  Google Scholar 

  70. Uchida N, et al. Pheochromocytoma multisystem crisis successfully treated by emergency surgery. Surg Today. 2010;40:990–6.

    PubMed  Google Scholar 

  71. Jessurun CR, et al. Pheochromocytoma-induced myocardial infarction in pregnancy. A case report and literature review. Tex Heart Inst J. 1993;20:120–2.

    CAS  PubMed  PubMed Central  Google Scholar 

  72. Greenblatt DY, Shenker Y, Chen H. The utility of metaiodobenzylguanidine (MIBG) scintigraphy in patients with pheochromocytoma. Ann Surg Oncol. 2008;15(3):900–5.

    PubMed  Google Scholar 

  73. Augoustides JG, et al. Vasopressin for hemodynamic rescue in catecholamine-resistant vasoplegic shock after resection of massive pheochromocytoma. Anesthesiology. 2004;101(4):1022–4.

    PubMed  Google Scholar 

  74. Kinney MAO, Narr BJ, Warner MA. Perioperative management of pheochromocytoma. J Cardiothorac Vasc Anesth. 2002;16(3):359–69.

    PubMed  Google Scholar 

  75. Pacak K. Approach to the patient. Preoperative management of the pheochromocytoma patient. J Clin Endocrinol Metab. 2007;92:4069–79.

    CAS  PubMed  Google Scholar 

  76. Dabrowska B, et al. Influence of alpha-adrenergic blockade on ventricular arrhythmias, QTc interval and heart rate variability in pheochromocytoma. J Hum Hypertens. 1995;9(11):925–9.

    CAS  PubMed  Google Scholar 

  77. Weingarten TN, et al. Comparison of two preoperative medical management strategies for laparoscopic resection of pheochromocytoma. Urology. 2010;76:508.e6–508.e11.

    PubMed  Google Scholar 

  78. Zhu Y, et al. Selective Alpha1-adrenoceptor antagonist (controlled release tablets in preoperative management of pheochromocytoma). Endocrinology. 2010;38:254–9.

    CAS  Google Scholar 

  79. Agrawal R, et al. Prospective study to compare peri-operative hemodynamic alterations following preparation for pheochromocytoma surgery by phenoxybenzamine or prazosin. World J Surg. 2014;38:716–23.

    PubMed  Google Scholar 

  80. Proye C, et al. Exclusive use of calcium channel blockers in preoperative and intraoperative control of pheochromocytomas: hemodynamics and free catecholamine assays in ten consecutive patients. Surgery. 1989;106(6):1149–54.

    CAS  PubMed  Google Scholar 

  81. Banfi C, et al. Central extracorporeal life support in pheochromocytoma crisis. Ann Thorac Surg. 2012;93(4):1303–5.

    PubMed  Google Scholar 

  82. Sojod G, et al. Successful extracorporeal membrane oxygenation treatment for pheochromocytoma-induced acute cardiac failure. Am J Emerg Med. 2012;30(6):1017.e1–3.

    PubMed  Google Scholar 

  83. Brunaud L, et al. Both preoperative alpha and calcium channel blockade impact intraoperative hemodynamic stability similarly in the management of pheochromocytoma. Surgery. 2014;156:1410–8.

    PubMed  Google Scholar 

  84. Morton A. Magnesium sulphate for phaeochromocytoma crisis. Emerg Med Australas. 2007;19:482.

    PubMed  Google Scholar 

  85. Lord MS, Augoustides JGT. Perioperative management of pheochromocytoma: focus on magnesium, clevidipine, and vasopressin. J Cardiothorac Vasc Anesth. 2012;26(3):526–31.

    CAS  PubMed  Google Scholar 

  86. James MF, Cronje L. Pheochromocytoma crisis: the use of magnesium sulfate. Anesth Analg. 2004;99:680–6.

    PubMed  Google Scholar 

  87. Perry RR, et al. Surgical management of pheochromocytoma with metyrosine. Ann Surg. 1990;212(5):621–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  88. Steinsapir J, et al. Metyrosine and pheochromocytoma. Arch Intern Med. 1997;157(8):901–6.

    CAS  PubMed  Google Scholar 

  89. Muller G, et al. Pheochromocytoma revealed by acute heart failure. When should we operate? Langenbeck’s Arch Surg. 2013;398:729–33.

    CAS  Google Scholar 

  90. Grinda J-M, et al. Unusual cardiogenic shock due to pheochromocytoma: recovery after bridge-to-bridge (extracorporeal life support and DeBakey ventricular assist device) and right surrenalectomy. J Thorac Cardiovasc Surg. 2006;131:913–4.

    PubMed  Google Scholar 

  91. Park S-M, et al. Pheochromocytoma-induced cardiogenic shock rescued by percutaneous cardiopulmonary bypass system. Circ J. 2009;73:1753–5.

    PubMed  Google Scholar 

  92. Lo CY, et al. Adrenal pheochromocytoma remains a frequently overlooked diagnosis. Am J Surg. 2000;179:212–5.

    CAS  PubMed  Google Scholar 

  93. Lassnig E, et al. Pheochromocytoma crisis presenting with shock and tako-tsubo-like cardiomyopathy. Int J Cardiol. 2009;134:e138–40.

    PubMed  Google Scholar 

  94. Scholten A, et al. Pheochromocytoma crisis is not a surgical emergency. J Clin Endocrinol Metab. 2013;98:581–91.

    CAS  PubMed  Google Scholar 

  95. Keely E. Endocrine causes of hypertension in pregnancy – when to start looking for zebras. Semin Perinatol. 1998;22(6):471–84.

    CAS  PubMed  Google Scholar 

  96. Lata I, Sahu S. Management of paroxysmal hypertension due to incidental pheochromocytoma in pregnancy. J Emerg Trauma Shock. 2011;4(3):415–7.

    PubMed  PubMed Central  Google Scholar 

  97. Dugas G, et al. Pheochromocytoma and pregnancy: a case report and review of anesthetic management. Can J Anesth. 2004;51(2):134–8.

    PubMed  Google Scholar 

  98. Solorzano CC, et al. Outcomes of pheochromocytomas management in the laparoscopic Era. Ann Surg Oncol. 2007;14(10):3004–10.

    PubMed  Google Scholar 

  99. Lee J, et al. Open and laparoscopic adrenalectomy: analysis of the national surgical quality improvement program. J Am Coll Surg. 2008;206:953–61.

    PubMed  Google Scholar 

  100. Efelbein DM, et al. Comparison of laparoscopic versus open adrenalectomy: results from American college of surgeons-national surgery quality improvement project. J Surg Res. 2013;184:216–20.

    Google Scholar 

  101. Schreinemakers JMJ, Elias SG, Borel Rinkes IH. Retroperitoneal endoscopic versus conventional open adrenalectomy: a cost analysis. J Laparoendosc Adv Surg Tech. 2008;18(5):707–12.

    Google Scholar 

  102. Eichhorn-Wharry LI, Talpos GB, Rubinfeld I. Laparoscopic versus open adrenalectomy: another look at outcome using the clavien classification syndrome. Surgery. 2012;152:1090–5.

    PubMed  Google Scholar 

  103. Kiernan CM, et al. Predictors of hemodynamic instability during surgery for pheochromocytoma. Ann Surg Oncol. 2014;21:3965–871.

    Google Scholar 

  104. Juszczak K, Drewa T. Adrenergic crisis due to pheochromocytoma – practical aspects. A short review. Cent Eur J Urol. 2014;67:153–5.

    Google Scholar 

  105. Amar L, et al. Genetic testing in pheochromocytoma or functional paraganglioma. J Clin Oncol. 2005;23:8812–8.

    CAS  PubMed  Google Scholar 

  106. Bryant J, et al. Pheochromocytoma: the expanding genetic diagnosis. J Natl Cancer Inst. 2003;95:1196–204.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA, 19104, USA

    Lindsay E. Kuo MD, MBA

  2. Department of Surgery, University of Pennsylvania, Philadelphia, PA, 19104, USA

    Douglas L. Fraker MD

Authors
  1. Lindsay E. Kuo MD, MBA
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Douglas L. Fraker MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Douglas L. Fraker MD .

Editor information

Editors and Affiliations

  1. Trauma, Surgical Critical Care, Emergency Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA

    Niels D. Martin

  2. Trauma, Surgical Critical Care, Emergency Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA

    Lewis J. Kaplan

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Kuo, L.E., Fraker, D.L. (2016). Hyperadrenergic Crisis. In: Martin, N.D., Kaplan, L.J. (eds) Principles of Adult Surgical Critical Care. Springer, Cham. https://doi.org/10.1007/978-3-319-33341-0_32

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-33341-0_32

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-33339-7

  • Online ISBN: 978-3-319-33341-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation